Aberdeen Group Boosts Stake in GE HealthCare Technologies

Institutional investor increases holdings in medical tech company by 55.6% in Q3

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Aberdeen Group plc, an institutional investor, boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 55.6% during the 3rd quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 174,328 shares of the company's stock, worth $13,092,000 at the end of the quarter.

Why it matters

The increase in Aberdeen Group's stake in GE HealthCare Technologies reflects growing investor interest in the medical technology company, which develops and markets a range of diagnostic imaging systems, patient monitoring equipment, and other healthcare products and services.

The details

According to the 13F filing, Aberdeen Group acquired an additional 62,263 shares of GE HealthCare Technologies during the 3rd quarter, bringing its total holdings to 174,328 shares. The company's stock has seen strong performance, rising over 27% in the past year as it benefits from increased demand for its products and services in the healthcare sector.

  • Aberdeen Group filed its 13F report for the 3rd quarter of 2026 on February 20, 2026.

The players

Aberdeen Group plc

An institutional investor and asset management firm based in Aberdeen, Scotland.

GE HealthCare Technologies Inc.

A global medical technology and diagnostics company that develops, manufactures, and markets a broad range of healthcare products and services.

Got photos? Submit your photos here. ›

The takeaway

The increase in Aberdeen Group's stake in GE HealthCare Technologies reflects the growing investor confidence in the company's ability to capitalize on the increasing demand for medical technology and diagnostic solutions in the healthcare industry.